Neoral (cyclosporine, modified)

Manufacturer:
misc.
Route of Administration: 
Oral
Site of Care:
Outpatient
Website: 
    Enrollment Forms:
    Synergen Prescription Form

    Approved Indication:

    • prophylaxis of organ rejection in kidney, liver, and heart allogenic transplants
    • treatment of patients with severe, active rheumatoid arthritis where the disease has not adequately responded to methotrexate
    • treatment of adult, nonimmunocompromised patients with severe, recalcitrant plaque psoriasis who have failed to respond to at least one systemic therapy or for whom other systemic therapies are contraindicated or cannot be tolerated

    Conditions:

    • Solid Organ Transplant
    • Rheumatoid Arthritis
    • Plaque Psoriasis

    Therapeutic Area:

    • Cardiology
    • Dermatology
    • Hepatology
    • Nephrology
    • Rheumatology
    • Transplant